Q92731 (ESR2_HUMAN) Homo sapiens (Human)

Estrogen receptor beta UniProtKBInterProSTRINGInteractive Modelling

530 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 8; Isoform 9; ) Identical sequences: Homo sapiens: Q7LCB3

Sequence Features

Add
 84G -> V (found in a patient with a 46,XY disorder of sex development; unknown pathological significance; no change in positive regulation of DNA-binding transcription factor activity; dbSNP:rs1460814363) VAR_081786 dbSNP
 181Missing (found in a patient with a 46,XY disorder of sex development; unknown pathological significance; shows increased positive regulation of DNA-binding transcription factor activity; dbSNP:rs750091675) VAR_081787 dbSNP
 314K -> R (in ODG8; completely inactive in positive regulation of DNA-binding transcription factor activity; dbSNP:rs1567753148) VAR_081788 dbSNP
 426L -> R (found in a patient with a 46,XY disorder of sex development; unknown pathological significance; shows a higher positive regulation of DNA-binding transcription factor activity; dbSNP:rs1217623435) VAR_081789 dbSNP
 149-214Nuclear receptor
 149-169NR C4-type
 185-209NR C4-type
 12-125Estrogen receptor beta, N-terminal
IPR021064PF12497
 148-216Zinc finger, nuclear hormone receptor-type
IPR001628PF00105
 285-480Nuclear hormone receptor, ligand-binding domain
IPR000536PF00104

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRange
HUMAN ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH KB095285 AND CIA12 COACTIVATOR P… Heteromer
Q9HCD5;
KB0;4zi1262-502
Assess
Crystal Structure of Estrogen Receptor beta complexed with WAY-338 Heteromer
Q15788;
338;1u3r263-501
Assess
Crystal Structure of Estrogen Receptor Beta Complexed with WAY-555 Heteromer
Q15788;
555;2nv7263-500
Assess
Crystal structure of estrogen receptor beta complexed with 3-Bromo-6-hydroxy-2-(4-hydroxy-phenyl)-i… Heteromer
Q15788;
789;1zaf263-500
Assess
Crystal structure of phosphorylated estrogen receptor beta ligand binding domain Heteromer
Q15788;
EST;3oll262-498
Assess
Stapled peptide bound to Estrogen Receptor Beta Heteromer
Q15596;
YJD;2yjd263-497
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-697 Heteromer
Q15788;
697;1x76263-497
Assess
Crystal Structure of Estrogen Receptor beta complexed with WAY-797 Heteromer
Q15788;
797;1u3s263-497
Assess
Crystal structure of estrogen receptor beta complexed with 1-chloro-6-(4-hydroxy-phenyl)-naphthalen… Heteromer
Q15788;
4NA;1yy4263-497
Assess
Fragment-Based Design of novel Estrogen Receptor Ligands Heteromer
Q15788;
W23;3omq264-497
Assess
Fragment-Based Design of novel Estrogen Receptor Ligands Heteromer
Q15788;
W14;3omp264-497
Assess
Crystal structure of estrogen receptor beta ligand binding domain Heteromer
Q15788;
EST;3ols264-497
Assess
Fragment-Based Design of novel Estrogen Receptor Ligands Heteromer
Q15788;
WV7;3omo264-497
Assess
A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen recept…homo-2-mer OHT;2fsz260-501
Assess
Estrogen receptor beta ligand binding domain in complex with a Benzopyran agonisthomo-2-mer JJ3;2jj3260-501
Assess
HUMAN OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH PARTIAL AGONIST GENISTEINhomo-2-mer GEN;1qkm260-500
Assess
Human estrogen receptor beta ligand-binding domain in complex with compound 45homo-2-mer FBR;2giu260-500
Assess
Estrogen receptor beta ligand-binding domain complexed to a benzopyran ligandhomo-2-mer DC8;2z4b260-500
Assess
Estrogen receptor beta ligand-binding domain complexed to a benzopyran ligandhomo-2-mer 3AS;2qtu260-500
Assess
Crystal Structure of ER beta bound to Estradiolhomo-2-mer EST;5toa262-501
Assess
Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of…homo-2-mer I0G;2i0g260-498
Assess
Sulfonamides as selective Estrogen Receptor beta Agonists.homo-2-mer SU4;SO4;2yly260-498
Assess
Crystal structure of estrogen receptor beta complexed with way-202196homo-2-mer 196;1yye263-500
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-244homo-2-mer 244;1x78263-500
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH ERB-041homo-2-mer 041;1x7b263-500
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH GENISTEINhomo-2-mer GEN;1x7j263-497
Assess
Crystal Structure of Estrogen Receptor beta complexed with CL-272homo-2-mer 272;1u3q263-497
Assess
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,12…monomer ETC;1l2j261-501
Assess
Estrogen Receptor beta with Selective Triazine Modulatormonomer MON;1nde261-500
Assess
Estrogen Receptor in complex with proline-flanked LXXLL peptidesmonomer EST;4j26261-498
Assess
Estrogen Receptor in complex with proline-flanked LXXLL peptidesmonomer EST;4j24262-498
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-397monomer 397;1u9e263-497
Assess

Homology models

Oligo-stateQMEANTemplateRangeSeq id (%)Ligands
monomer -4.72 4nqa.2.A142-498
32.93ZN;
Assess
monomer -4.98 4nqa.1.A147-496
34.88ZN;
Assess
monomer -4.68 3dzy.1.B146-497
23.10ZN;
Assess

Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANTemplateRangeSeq id (%)
Isoform 2monomerZN;-4.695uan.1.A147-490
31.37
Assess
Isoform 3monomerZN;-2.725uan.1.B149-321
36.31
Assess
Isoform 3monomerZN;-4.483dzy.1.A146-322
33.75
Assess
Isoform 3monomerZN;-4.404iqr.2.A147-322
31.41
Assess
Isoform 4monomerZN;-4.885uan.1.B148-482
26.73
Assess
Isoform 4monomerZN;-4.724nqa.2.A142-483
32.17
Assess
Isoform 5homo-2-mer-0.531qkn.1.B262-467
92.49
Assess
Isoform 5monomerZN;-3.765uan.1.B149-480
29.51
Assess
Isoform 5monomerZN;-3.994nqa.1.A147-407
37.30
Assess
Isoform 5monomerZN;-3.863dzy.1.A147-407
37.30
Assess
Isoform 5monomerZN;-3.975uan.1.A147-407
37.30
Assess
Isoform 6monomerZN;-4.394nqa.2.A142-470
32.45
Assess
Isoform 6monomerZN;-4.884nqa.2.B143-470
25.47
Assess
Isoform 6monomerZN;-4.745uan.1.A147-470
32.45
Assess
Isoform 6monomerZN;-4.933dzy.1.A146-470
32.23
Assess
Isoform 7monomerZN;-3.994nqa.1.A142-405
31.87
Assess
Isoform 7monomerZN;-4.704nqa.1.B144-405
27.38
Assess
Isoform 7monomer-2.765aau.1.A318-412
53.61
Assess
Isoform 7monomer-3.536fx0.1.A249-381
33.49
Assess
Isoform 8monomerZN;-4.994nqa.1.B144-364
28.96
Assess
Isoform 8monomerZN;-4.634nqa.2.B144-364
28.96
Assess
Isoform 9monomerZN;-4.655uan.1.B148-472
26.54
Assess
Isoform 9monomerZN;-3.894nqa.1.A147-407
37.30
Assess
Isoform 9monomerZN;-3.823dzy.1.A147-407
37.30
Assess
Isoform 9monomer-4.793dzu.1.B146-471
23.42
Assess
Isoform 9monomerZN;-3.845uan.1.A147-407
37.30
Assess